Rydex Biotechnology Inv (RYOIX)
Rydex Biotechnology Inv operates in the Asset Management industry of the Financial Services sector, headquartered in New York, NY, US. The stock last traded at $91.55, up 0.19% on the session, giving a market capitalisation of $96.6M. Its beta of 0.68 implies it has historically moved less than the broad market.
Under normal circumstances, the fund invests substantially all (at least 80%) of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified.
Rydex Biotechnology Inv is most often compared with the following Financial Services names: